allergic rhinitis
Conditions
Interventions
Control group:No intervention
Acupuncture Group:Acupuncture
Sponsors
China Academy of Chinese Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: (1) age of 18-65 years old, both sexes; (2) meets the diagnostic criteria of allergic rhinitis of lung-spleen qi deficiency and is in the attack stage of the disease; (3) The rhinitis symptom score of allergic rhinitis of lung-spleen qi deficiency was =6 points, which met the diagnostic criteria of moderate to severe rhinitis. (4) The patient had not used anti-allergic drugs or received other treatment in the past week; (1 week washout period) (5) no other intervention treatment or measures during the study; (6) voluntarily participated in the clinical observation and signed the informed consent; (7) able to obey the doctor's treatment arrangements, can cooperate with the doctor's treatment and follow-up; (8) The patient had normal consciousness, could correctly express the acupuncture sensation, and acted with cooperation. (9) adults with independent behavior ability and willing to cooperate with treatment, tongue pulse examination and filling in the questionnaire.
Exclusion criteria
Exclusion criteria: (1) patients with severe primary diseases of cardiovascular, cerebrovascular, liver, kidney and hematopoietic system, psychiatric patients, severe nasal polyps, deviation of nasal septum, sinusitis, nasal tumors or congenital malformation of nasal cavity; (2) patients with asthma, bronchitis and other upper respiratory diseases; (3) patients currently receiving treatment; (4) currently menstruating, pregnant or lactating women; (5) those who suffer from other diseases and cannot cooperate with the treatment; (6) if the skin at the operation site has obvious rupture and bleeding, which is not suitable for needling; (7) dizzy with acupuncture or blood loss.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Tongue and pulse; | — |
Secondary
| Measure | Time frame |
|---|---|
| Total nasal symptom score;Total Non-Nasal Symptom Score;Visual analogue scale;Rhinoconjunctivitis Quality of Life Questionnaire; | — |
Countries
China
Contacts
Public ContactTao Huang
China Academy of Chinese Medical Sciences
Outcome results
None listed